AACR Special Conference in Cancer Research: Acute Lymphoblastic Leukemia
In association with the AACR Hematologic Malignancies Working Group
March 7-9, 2025
Hilton San Diego Bayfront
San Diego, California
Conference Cochairs:
Charles G. Mullighan, St. Jude Children’s Research Hospital, Memphis, Tennessee
Elizabeth A. Raetz, New York University Perlmutter Cancer Center, New York, New York
Wendy Stock, University of Chicago, Chicago, Illinois
The upcoming conference on Acute Lymphoblastic Leukemia (ALL) aims to bridge the gap between scientific research and clinical practice, offering invaluable insights for both scientists and clinicians. Plenary sessions will delve into key areas such as cellular therapies, B-ALL and T-ALL biology, and molecularly targeted therapies, fostering a comprehensive understanding of the disease’s complexities. Discussions on targeted immunotherapies and advancements in diagnostics and prognostics will equip attendees with the latest tools for improving patient outcomes. By exploring future directions in ALL therapy, the conference will encourage collaboration and innovation, ultimately driving progress in treatment strategies. This event promises to serve as a critical platform for sharing knowledge, fostering partnerships, and shaping the future landscape of ALL care.
Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available
